Text Size
275 studies found for:    biogen | biogen

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Completed A Bioequivalence Study of Serum Free Avonex and Serum Containing Avonex in Healthy Volunteers
Condition: Multiple Sclerosis
Interventions: Drug: Serum containing Avonex;   Drug: Serum Free Avonex
22 Completed Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Natalizumab;   Drug: Placebo
23 Completed Immunogenicity and Safety Study of Serum-Free Avonex
Condition: Multiple Sclerosis
Intervention: Drug: Interferon beta-1a
24 Completed Pharmacodynamic Study to Better Understand the Therapeutic Response and Immunomodulatory Effects of Avonex in Multiple Sclerosis (MS) Patients and Healthy Volunteers
Condition: Multiple Sclerosis
Intervention: Drug: Interferon beta-1a (Avonex)
25 Completed Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Interferon beta-1a
26 Completed Patient Satisfaction Study of Single-Use Autoinjector for the Delivery of Pre-Filled Avonex Syringe
Condition: Multiple Sclerosis
Interventions: Drug: Interferon beta-1a;   Device: Single-use autoinjector
27 Completed GER-009-06-AVX Early Therapy in Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention:
28 Completed Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors
Conditions: Tumors;   Lymphoma
Intervention: Drug: CNF2024
29 Completed Pharmacokinetics Profile Study of BG00012 Standard Formulation and BG00012 Active Pharmaceutical Ingredient
Condition: Healthy
Intervention: Drug: BG00012
30 Terminated Oral BG9928 in Patients With Heart Failure and Renal Insufficiency
Conditions: Heart Failure;   Renal Insufficiency
Interventions: Drug: Tonapofylline;   Drug: Placebo
31 Terminated BG9924 in Combination With Methotrexate for Subjects With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: BG9924;   Other: Placebo Comparator
32 Completed Demonstrate the Bioequivalence of Interferon Beta-1a (INFB) Manufactured by Two Different Processes in Healthy Volunteers
Condition: Multiple Sclerosis
Interventions: Drug: Interferon beta-1a (current approved manufacturing process invloving FBS);   Drug: Interferon beta-1a (new process, manufactured without FBS)
33 Completed Pregnancy Exposure Registry for AVONEX
Conditions: Prenatal Exposure Delayed Effects;   Multiple Sclerosis;   Pregnancy
Intervention:
34 Completed Is IFN-beta Treatment in MS Useful After a Washout Period in Patients With Neutralizing Antibodies to Interferon Beta
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Interferon-beta-1a;   Drug: methylprednisolone
35 Completed Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Interferon-beta-1a;   Drug: Simvastatin;   Drug: Placebo
36 Completed A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients "TIMER" Study
Condition: Relapsing Remitting Multiple Sclerosis (RRMS)
Intervention: Drug: Natalizumab (Tysabri®)
37 Withdrawn BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
Condition: Rheumatoid Arthritis
Interventions: Drug: BIIB057;   Drug: Placebo
38 Terminated Phase 3 Extension Study of Dexpramipexole in ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Dexpramipexole
39 Terminated Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
Condition: Non-Hodgkin's Lymphoma
Interventions: Drug: Zevalin (ibritumomab tiuxetan);   Drug: Rituxan (rituximab)
40 Completed Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A
Condition: Severe Hemophilia A
Intervention: Drug: rFVIIIFc
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years